Prime Share Price
NASDAQ: PRME | Small Cap | HealthcarePrime Stock Performance
Prime Share Price Today
As of 22 November 2026, Prime Medicine, Inc.'s share price is $3.57. The stock opened at $3.67, compared to its previous close of $3.83. During today's trading session, Prime Medicine, Inc.'s share price traded between $3.50 and $3.91, with an average price of $3.70. Over the past 52 weeks, the stock has recorded a high of $5.91 and a low of $2.67. In terms of performance, Prime Medicine, Inc.'s share price has risen by 0.28% over the last six months and is down 6.54% on a year-on-year basis.
Prime Share Price Chart
Prime Quarterly Profit & Loss
All figures in USD
Prime Annual Profit & Loss
All figures in USD
Prime Balance Sheet
All figures in USD Million
Prime Cash Flow
All figures in USD Million
Corporate Actions
About Prime
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
Prime Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $4.76 | $3.55 | -24.87% |
Oct 2026 | $3.04 | $4.72 | +54.16% |
Sep 2026 | $3.55 | $3.06 | -16.03% |
Aug 2026 | $2.89 | $3.65 | +25.21% |
Jul 2026 | $3.70 | $2.92 | -20.79% |
Jun 2026 | $3.52 | $3.68 | +3.37% |
May 2026 | $3.46 | $3.56 | +0.56% |
Apr 2026 | $3.56 | $3.54 | +1.72% |
Mar 2026 | $4.48 | $3.48 | -24.84% |
Feb 2026 | $3.76 | $4.63 | +21.20% |
Jan 2026 | $3.50 | $3.82 | +10.72% |
Dec 2025 | $3.73 | $3.45 | -9.69% |

